Methodology and applications of disease biomarker identification in human serum.

Methodology and applications of disease biomarker identification in human serum.

Item
http://www.wikidata.org/entity/Q37574961
Putative biomarkers and targets of estrogen receptor negative human breast cancerEarly biomarkers of joint damage in rheumatoid and psoriatic arthritisDye-doped silica nanoparticle labels/protein microarray for detection of protein biomarkersDetection of femtomolar proteins by nonfluorescent ZnS nanocrystal clustersDo serum biomarkers really measure breast cancer?Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycleMultiplexed protein analysis using encoded antibody-conjugated microbeads.Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry.Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences.Accurate Quantification of Disease Markers in Human Serum Using Iron Oxide Nanoparticle-linked Immunosorbent Assay.Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer
P2860

Methodology and applications of disease biomarker identification in human serum.

Item
http://www.wikidata.org/entity/Q37574961
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methodology and applications of disease biomarker identification in human serum.
@en
Methodology and applications of disease biomarker identification in human serum.
@nl
type
label
Methodology and applications of disease biomarker identification in human serum.
@en
Methodology and applications of disease biomarker identification in human serum.
@nl
prefLabel
Methodology and applications of disease biomarker identification in human serum.
@en
Methodology and applications of disease biomarker identification in human serum.
@nl
P1433
P1476
P2093
P2860
P304
P31
P478
P577
P698
P921
P932
P1433
P1476
Methodology and applications of disease biomarker identification in human serum.
@en
P2093
P2860
P304
P31
P478
P577
P698
P921
P932